Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin's Lymphoma(NHL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01527838
What this trial is testing

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Hodgkin's DiseaseChronic Lymphocytic Leukemia (CLL)+2 more
Fate Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Large-scale testing (Phase 3)UnknownNCT00003338
What this trial is testing

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Gilead Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT04358458
What this trial is testing

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Diffuse Large B-cell LymphomaFollicular LymphomaMarginal Zone Lymphoma+5 more
Genmab 46
Early research (Phase 1)UnknownNCT05127135
What this trial is testing

Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Who this might be right for
T-Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin LymphomaT-cell Acute Lymphoblastic Lymphoma
Fundamenta Therapeutics, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00004171
What this trial is testing

Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Not applicableActive Not RecruitingNCT04537871
What this trial is testing

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaHematopoietic and Lymphoid Cell Neoplasm+4 more
City of Hope Medical Center 350
Not applicableStudy completedNCT00985699
What this trial is testing

S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 337
Testing effectiveness (Phase 2)Study completedNCT00521014
What this trial is testing

GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)Ended earlyNCT00080847
What this trial is testing

S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage III Adult Diffuse Large Cell Lymphoma+1 more
National Cancer Institute (NCI) 160
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT03309878
What this trial is testing

Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell LymphomaRecurrent Transformed B-Cell Non-Hodgkin Lymphoma+3 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Ended earlyNCT02253992
What this trial is testing

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Advanced Solid TumorsAdvanced B-cell NHL
Bristol-Myers Squibb 232
Large-scale testing (Phase 3)Study completedNCT00185393
What this trial is testing

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

Who this might be right for
Lymphoma, Non-Hodgkin
Bayer 414
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00901225
What this trial is testing

Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaNon-Hodgkins LymphomaHodgkins Disease
Duke University 21
Next Page